These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10730928)

  • 1. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum.
    Ierardi E; Principi M; Rendina M; Francavilla R; Ingrosso M; Pisani A; Amoruso A; Panella C; Francavilla A
    J Clin Gastroenterol; 2000 Mar; 30(2):200-2. PubMed ID: 10730928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study.
    González-Lama Y; Abreu L; Vera MI; Pastrana M; Tabernero S; Revilla J; Durán JG; Escartin P
    Inflamm Bowel Dis; 2005 Jan; 11(1):8-15. PubMed ID: 15674108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectourethroperineal fistula in Crohn's disease.
    Stamler JS; Bauer JJ; Janowitz HD
    Am J Gastroenterol; 1985 Feb; 80(2):111-2. PubMed ID: 3969998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
    Lowry PW; Weaver AL; Tremaine WJ; Sandborn WJ
    Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease.
    Casson DH; Eltumi M; Tomlin S; Walker-Smith JA; Murch SH
    Gut; 2000 Sep; 47(3):436-40. PubMed ID: 10940284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease.
    Tamaki H; Nakase H; Matsuura M; Inoue S; Mikami S; Ueno S; Uza N; Kitamura H; Kasahara K; Chiba T
    J Gastroenterol; 2008; 43(10):774-9. PubMed ID: 18958546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance.
    Ierardi E; Principi M; Francavilla R; Pisani A; Rendina M; Ingrosso M; Guglielmi FW; Panella C; Francavilla A
    Aliment Pharmacol Ther; 2001 Mar; 15(3):371-7. PubMed ID: 11207512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus for Crohn's disease.
    Ruddock B
    Issues Emerg Health Technol; 2006 Sep; (88):1-4. PubMed ID: 16981314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ; Sandborn WJ; Tremaine WJ
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
    Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
    Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas.
    Ng SC; Plamondon S; Gupta A; Burling D; Swatton A; Vaizey CJ; Kamm MA
    Am J Gastroenterol; 2009 Dec; 104(12):2973-86. PubMed ID: 19755971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A; Kirschner BS; Werlin SL; Parker-Hartigan L; Daum F; Freeman KB; Balint JP; Day AS; Griffiths AM; Zurakowski D; Ferry GD; Leichtner AM
    J Pediatr; 2000 Dec; 137(6):794-9. PubMed ID: 11113835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's disease.
    Gerich ME; Pardi DS; Bruining DH; Kammer PP; Becker BD; Tremaine WT
    Inflamm Bowel Dis; 2013 May; 19(6):1107-11. PubMed ID: 23518805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory enterovesical and duodenocolic fistulas in Crohn's disease successfully managed with tacrolimus.
    Fukuda A; Nakase H; Seno H; Nabeshima M; Sawada M; Chiba T
    J Gastroenterol; 2005 Apr; 40(4):433-5. PubMed ID: 15870981
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.
    Rice SA; Woo PN; El-Omar E; Keenan RA; Ormerod AD
    BMC Res Notes; 2013 Jan; 6():19. PubMed ID: 23331739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.
    Ng SC; Arebi N; Kamm MA
    Inflamm Bowel Dis; 2007 Feb; 13(2):129-34. PubMed ID: 17206694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.